Published in Antimicrob Agents Chemother on August 01, 1996
Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother (2002) 7.73
AmpC beta-lactamases. Clin Microbiol Rev (2009) 7.14
Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Antimicrob Agents Chemother (1997) 7.07
ISCR elements: novel gene-capturing systems of the 21st century? Microbiol Mol Biol Rev (2006) 5.50
beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob Agents Chemother (1998) 3.76
Catalytic properties of class A beta-lactamases: efficiency and diversity. Biochem J (1998) 3.47
Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother (1998) 3.17
Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother (2000) 2.96
A novel integron in Salmonella enterica serovar Enteritidis, carrying the bla(DHA-1) gene and its regulator gene ampR, originated from Morganella morganii. Antimicrob Agents Chemother (2000) 2.85
Survey of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J Clin Microbiol (1998) 2.66
blaCTX-M-2 is located in an unusual class 1 integron (In35) which includes Orf513. Antimicrob Agents Chemother (2002) 2.47
A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob Agents Chemother (1999) 2.40
Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother (2000) 2.23
Identification and expression of cephamycinase bla(CMY) genes in Escherichia coli and Salmonella isolates from food animals and ground meat. Antimicrob Agents Chemother (2001) 2.22
Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J Clin Microbiol (2000) 2.11
Characterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca. Antimicrob Agents Chemother (1998) 1.85
Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded beta-lactamase from a New York City Klebsiella pneumoniae clinical isolate. Antimicrob Agents Chemother (2001) 1.81
Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens. Antimicrob Agents Chemother (1999) 1.68
A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob Agents Chemother (1997) 1.64
Chromosomally encoded ampC-type beta-lactamase in a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother (1998) 1.61
Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated beta-lactamase from an Escherichia coli strain isolated in Spain. Antimicrob Agents Chemother (2000) 1.56
Biochemical-genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei. Antimicrob Agents Chemother (2000) 1.54
Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey. J Clin Microbiol (2004) 1.48
First detection of the Ambler class C 1 AmpC beta-lactamase in Citrobacter freundii by a new, simple double-disk synergy test. J Clin Microbiol (2006) 1.44
Characterization of a novel plasmid-mediated cephalosporinase (CMY-9) and its genetic environment in an Escherichia coli clinical isolate. Antimicrob Agents Chemother (2002) 1.43
Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 beta-lactamase in a university hospital in Taiwan. J Clin Microbiol (2002) 1.37
Horizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19. Antimicrob Agents Chemother (2006) 1.22
Nucleotide sequence of the chromosomal ampC gene of Enterobacter aerogenes. Antimicrob Agents Chemother (2000) 1.06
Laboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of Japan. J Clin Microbiol (2010) 1.05
Novel plasmid-encoded class C beta-lactamase (MOX-2) in Klebsiella pneumoniae from Greece. Antimicrob Agents Chemother (2002) 0.88
What's New in beta-lactamases? Curr Infect Dis Rep (2001) 0.88
Structure-function studies of Ser-289 in the class C beta-lactamase from Enterobacter cloacae P99. Antimicrob Agents Chemother (1999) 0.84
Dissemination of SHV-12 and characterization of new AmpC-type beta-lactamase genes among clinical isolates of enterobacter species in Korea. J Clin Microbiol (2003) 0.83
Crystal structure of Mox-1, a unique plasmid-mediated class C β-lactamase with hydrolytic activity towards moxalactam. Antimicrob Agents Chemother (2014) 0.79
Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes. Antimicrob Agents Chemother (2010) 0.78
High occurrence of blaCMY-1 AmpC lactamase producing Escherichia coli in cases of complicated urinary tract infection (UTI) from a tertiary health care centre in north India. Indian J Med Res (2012) 0.77
BetalasEN: microdilution panel for identifying beta-lactamases present in isolates of Enterobacteriaceae. J Clin Microbiol (2002) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol (1987) 266.90
A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res (1979) 214.95
A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother (1995) 26.51
Fast and sensitive multiple sequence alignments on a microcomputer. Comput Appl Biosci (1989) 24.33
The use of analytical isoelectric focusing for detection and identification of beta-lactamases. J Gen Microbiol (1975) 19.91
The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci (1980) 17.57
More extended-spectrum beta-lactamases. Antimicrob Agents Chemother (1991) 11.28
ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type. Proc Natl Acad Sci U S A (1981) 8.21
A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection (1991) 6.78
Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother (1990) 6.11
Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future. Rev Infect Dis (1983) 5.57
Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob Agents Chemother (1996) 4.41
Sequence of the Citrobacter freundii OS60 chromosomal ampC beta-lactamase gene. Eur J Biochem (1986) 3.93
Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection (1990) 3.80
Sequence and comparative analysis of three Enterobacter cloacae ampC beta-lactamase genes and their products. Biochem J (1988) 3.66
Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase. Antimicrob Agents Chemother (1996) 3.56
Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1993) 3.44
Cloning, sequencing and analysis of the structural gene and regulatory region of the Pseudomonas aeruginosa chromosomal ampC beta-lactamase. Biochem J (1990) 3.20
Plasmid-mediated AmpC-type beta-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum beta-lactams, including moxalactam. Antimicrob Agents Chemother (1993) 3.19
Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants. Antimicrob Agents Chemother (1994) 3.09
Characterization of a plasmid-borne and constitutively expressed blaMOX-1 gene encoding AmpC-type beta-lactamase. Gene (1994) 3.08
Cloning and sequence analysis of blaBIL-1, a plasmid-mediated class C beta-lactamase gene in Escherichia coli BS. Antimicrob Agents Chemother (1994) 2.74
Characterization of the plasmid mediated beta-lactamase BIL-1. J Antimicrob Chemother (1992) 2.48
Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae. J Antimicrob Chemother (1993) 2.37
Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect (2001) 5.91
Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases. Antimicrob Agents Chemother (1996) 5.36
Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol (2003) 4.79
A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection (1992) 4.52
Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob Agents Chemother (1996) 4.41
Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob Agents Chemother (1998) 4.24
Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection (1990) 3.80
Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase. Antimicrob Agents Chemother (1996) 3.56
Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 IN protein in vitro. Virology (1992) 3.43
Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol (1998) 3.34
Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States. Antimicrob Agents Chemother (1985) 2.66
A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob Agents Chemother (1999) 2.40
Acculturation and low-birthweight infants among Latino women: a reanalysis of HHANES data with structural equation models. Am J Public Health (1996) 2.30
Plasmid-encoded AmpC beta-lactamases: how far have we gone 10 years after the discovery? Yonsei Med J (1998) 1.88
A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob Agents Chemother (1997) 1.64
Discrimination of Burkholderia gladioli from other Burkholderia species detectable in cystic fibrosis patients by PCR. J Clin Microbiol (1998) 1.60
Spread of the serotype 23F multidrug-resistant Streptococcus pneumoniae clone to South Korea. Microb Drug Resist (1997) 1.59
Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother (1998) 1.58
Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens. Infection (1996) 1.50
Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta- lactamase: parallel outbreaks due to multiple plasmid transfer. J Clin Microbiol (1996) 1.45
Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis. Infection (1987) 1.43
Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR. J Clin Microbiol (1999) 1.43
Molecular procedure for rapid detection of Burkholderia mallei and Burkholderia pseudomallei. J Clin Microbiol (1998) 1.42
Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3. Mol Pharmacol (1995) 1.42
Single channel currents at six microsecond resolution elicited by acetylcholine in mouse myoballs. J Physiol (1998) 1.25
Two cases of Chromobacterium violaceum infection after injury in a subtropical region. J Clin Microbiol (1999) 1.24
Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle. J Biol Chem (2000) 1.24
Production of monoclonal antibodies to lipoarabinomannan-B and use in the detection of mycobacterial antigens in sputum. Yonsei Med J (1990) 1.23
Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. Am J Respir Crit Care Med (2001) 1.23
Facile synthesis of the tricyclic core of sarain A. 3-Oxidopyridinium betaine cycloaddition approach. Org Lett (1999) 1.15
Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3'-long terminal repeat transgene. J Exp Med (1994) 1.13
Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone. J Korean Med Sci (2001) 1.12
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007-2008. Commun Dis Intell Q Rep (2010) 1.11
Colorimetric microwell plate hybridization assay for detection of amplified Mycobacterium tuberculosis DNA from sputum samples. J Clin Microbiol (1995) 1.07
Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea. Clin Infect Dis (1996) 1.07
Simultaneous simulation of the serum profiles of two antibiotics and analysis of the combined effect against a culture of Pseudomonas aeruginosa. Chemotherapy (1982) 1.03
Trends in serotypes and antimicrobial susceptibility of group B streptococci isolated in Korea. J Infect Chemother (2000) 1.01
Neonatal intensive care unit outbreak caused by a strain of Klebsiella oxytoca resistant to aztreonam due to overproduction of chromosomal beta-lactamase. J Hosp Infect (2001) 1.00
Properties and gene structure of the Thermotoga maritima alpha-amylase AmyA, a putative lipoprotein of a hyperthermophilic bacterium. J Bacteriol (1997) 1.00
A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Diagn Microbiol Infect Dis (2001) 0.98
Case of sepsis caused by Bifidobacterium longum. J Clin Microbiol (1999) 0.97
Antimicrobial resistance patterns of Bacteroides fragilis group organisms in Korea. Yonsei Med J (1998) 0.97
Multiclonal emergence of ciprofloxacin-resistant clinical isolates of Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother (1994) 0.97
Pyogenic arthritis of the hip due to Campylobacter fetus--a case report. Yonsei Med J (1992) 0.92
Scrub typhus in Korea: importance of early clinical diagnosis in this newly recognized endemic area. Mil Med (1993) 0.92
Production of monoclonal antibody to a phenolic glycolipid of Mycobacterium tuberculosis and its use in detection of the antigen in clinical isolates. J Clin Microbiol (1992) 0.92
[Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins]. Infection (1990) 0.89
[Identification of enterotoxin-producing Clostridium perfringens by the polymerase chain reaction]. Kansenshogaku Zasshi (1993) 0.88
Bactericidal kinetics of various dosages of fleroxacin simulated in bacterial cultures. J Antimicrob Chemother (1988) 0.87
In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea. Antimicrob Agents Chemother (1992) 0.87
Open channel and competitive block of the embryonic form of the nicotinic receptor of mouse myotubes by (+)-tubocurarine. J Physiol (1996) 0.86
Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia/lymphoma after umbilical cord blood transplantation. Bone Marrow Transplant (2013) 0.86
Identification and quantification of juvenile hormones from different developmental stages of the cockroach Nauphoeta cinerea. Life Sci (1975) 0.85
Organelle purification and selective permeabilisation of the plasma membrane: two different approaches to study vacuoles of the filamentous fungus Ashbya gossypii. FEMS Microbiol Lett (1998) 0.85
Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil. Infection (1992) 0.85
Selection of antibiotics for treatment and prophylaxis of staphylococcal infections in cystic fibrosis patients. Infection (1990) 0.84
Influence of cholesterol supply on cell growth and differentiation in cultured enterocytes (CaCo-2). Digestion (1995) 0.84
Cytogenetic analysis of invasive breast cancer: a study of 27 Asian patients. Cancer Genet Cytogenet (2000) 0.84
Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors. Cell Signal (1998) 0.84
Antimicrobial susceptibility of Campylobacter fetus subsp. fetus isolated from blood and synovial fluid. Yonsei Med J (1994) 0.83
Active intracellular domain of Notch enhances transcriptional activation of CCAAT/enhancer binding protein beta on a rat pregnancy-specific glycoprotein gene. Biochemistry (2000) 0.83
[Causal illness attributions and healthcare utilization in fibromyalgia syndrome]. Schmerz (2006) 0.82
Application of serologic diagnosis of tsutsugamushi disease (scrub typhus) in Korea where the disease was recently recognized to be endemic. Yonsei Med J (1989) 0.82
Bioelectronic detection of point mutations using discrimination of the H63D polymorphism of the Hfe gene as a model. Mol Diagn (2000) 0.82
Some antioxidants inhibit, in a co-ordinate fashion, the production of tumor necrosis factor-alpha, IL-beta, and IL-6 by human peripheral blood mononuclear cells. Int Immunol (1994) 0.81
2'-Ribose-ferrocene oligonucleotides for electronic detection of nucleic acids. J Org Chem (2001) 0.81
Identification of potential influenza virus endonuclease inhibitors through virtual screening based on the 3D-QSAR model. SAR QSAR Environ Res (2009) 0.81
Alkylation of DNA and RNA by [14C]dimethylnitrosamine in hydroxyurea-synchronized regenerating rat liver. Cancer Res (1979) 0.81
Emerging antimicrobial resistance, plasmid profile and pulsed-field gel electrophoresis pattern of the endonuclease-digested genomic DNA of Neisseria gonorrhoeae. Yonsei Med J (2000) 0.81
Cardiobacterium hominis endocarditis--a case report. Yonsei Med J (1985) 0.80
Effects of high concentrations of sucrose in blood culture media with special reference to the cultivation of Salmonella typhi. Yonsei Med J (1975) 0.80
Erysipelothrix rhusiopathiae endocarditis. A case report. Yonsei Med J (1986) 0.80
Dystonia as a side effect of nonneuroleptics. J Am Acad Child Adolesc Psychiatry (1999) 0.80
Operational definitions for year 2000 objectives: Priority Area 1, Physical Activity and Fitness. Healthy People 2000 Stat Notes (1998) 0.80
Solid phase synthesis of carbocyclic l-2'-deoxynucleosides. Org Lett (2001) 0.80
[Prevention and therapy of acute radiation injuries of the skin and mucosa. I. Results of a German multicenter questionnaire]. Strahlenther Onkol (1998) 0.80
Actinomyces israelii and Eikenella corrodens isolation from a pleural effusion case. Yonsei Med J (1972) 0.80
Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres. Haemophilia (2015) 0.79
Effect of Na-hyaluronan on stromal and endothelial healing in experimental corneal alkali wounds. Ophthalmic Res (1999) 0.79
[High dosage brachytherapy and external irradiation of localized prostate carcinoma--results at the Kiel University Clinic]. Praxis (Bern 1994) (2001) 0.79
O6-methylguanine repair in liver cells in vivo: comparison between G1- and S-phase of the cell cycle. J Cancer Res Clin Oncol (1984) 0.78
In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany. J Antimicrob Chemother (1989) 0.78
Understanding the mode of action of L-nucleosides as antiviral agents: a molecular modeling approach. Nucleosides Nucleotides Nucleic Acids (2001) 0.77
Cultural and biochemical characteristics of clinical isolates of Aeromonas hydrophila. Yonsei Med J (1980) 0.77
Pasteurella multocida infection of the calf in a patient who had moxa cautery treatment for degenerative arthritis. Yonsei Med J (1982) 0.77
Shigella flexneri bacteremia: a case report. Yonsei Med J (1981) 0.77
Detection of Mycobacterium tuberculosis in clinical samples from patients with tuberculosis or other pulmonary diseases by polymerase chain reaction. Yonsei Med J (1992) 0.77
Penicillin and tetracycline susceptibility of Neisseria gonorrhoeae strains isolated during 1966 to 1975. Yonsei Med J (1976) 0.77
In-silico prediction of blood-brain barrier permeability. SAR QSAR Environ Res (2012) 0.77
Diagnostic usefulness of Vi-indirect fluorescent antibody test(Vi-IFAT) for typhoid fever--a prospective study. Yonsei Med J (1989) 0.76
Neisseria subflava infections--bacteriological aspects of two cases. Yonsei Med J (1975) 0.76
Isolation of Actinobacillus actinomycetemcomitans from the blood of a patient with subacute bacterial endocarditis. Yonsei Med J (1983) 0.76
Conformal treatment planning for interstitial brachytherapy. Strahlenther Onkol (1996) 0.76
Nocardia osteomyelitis in a pachymeningitis patient: an example of a difficult case to treat with antimicrobial agents. Yonsei Med J (1998) 0.75
Pulmonary nocardiosis in a renal transplant patient. Yonsei Med J (1987) 0.75